Skip to main content
Clinical Trials/JPRN-UMIN000009557
JPRN-UMIN000009557
Recruiting
N/A

The multimodarity imaging assesssment using MRI and US related to the associaton between the skeletal muscle and the liver. - The multimodarity imaging assessment of the association between the skeletal muscle and the liver.

niversity of Tsukuba0 sites70 target enrollmentDecember 16, 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Tsukuba
Enrollment
70
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 16, 2012
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Tsukuba

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Pacemaker claustrophobia

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
Phase 1
Phase 2a open label study of Fovista¿ (anti-PDGF agent) administered in combination with anti-VEGF therapy in subjects previously treated or treatment-naive.Subfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 20.0Level: PTClassification code 10071129Term: Neovascular age-related macular degenerationSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.1Level: LLTClassification code 10067791Term: Wet macular degenerationSystem Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]
EUCTR2015-000519-42-ITIVERIC bio, Inc.32
Active, Not Recruiting
Phase 1
Role of imaging in the evaluation of anatomic alterations in neovascular Age-Related Macular Degeneration (AMD) subjects: 18 month study of Fovista® (anti-PDGF therapy) administered in combination with anti-VEGF therapySubfoveal choroidal neovascularization secondary to Age-Related Macular Degeneration (AMD)MedDRA version: 18.0 Level: PT Classification code 10071129 Term: Neovascular age-related macular degeneration System Organ Class: 10015919 - Eye disordersMedDRA version: 18.0 Level: LLT Classification code 10067791 Term: Wet macular degeneration System Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]
EUCTR2015-000519-42-FROPHTHOTECH CORPORATIO32
Recruiting
Phase 1
Multi-modal MRI and artificial intelligence to explore the brain-gut interaction of functional constipation and the clinical study of integrated traditional Chinese and western medicine treatment
ITMCTR2100005047Jiangsu Provincial Hospital of TCM
Recruiting
N/A
The evalustion of fatty liver disease and post-surgical response in patients undergoing bariatric surgery
KCT0003527Gachon University Gil Medical Center75
Active, Not Recruiting
Phase 1
Prospektive Evaluation von Multimodality Imaging Verfahren (PET - CT - MRT - US - Bildfusion) bei malignen Tumoren der Kopf-Hals-RegioPatients with malignant Head and Neck Tumors - Diagnostic Imaging StudyMedDRA version: 9.1Level: LLTClassification code 10049516Term: Malignant tumor
EUCTR2007-004393-81-ATMedizinische Universität Innsbruck - Universitätsklinik für Radiodiagnostik (Radiologie I)270